John Carver
Australian National University, ACT, Australia
- This delegate is presenting an abstract at this event.

John Carver has recently taken up the position of Director of the Research School of Chemistry at the Australian National University in Canberra. He undertook his undergraduate (Honours) degree in Chemistry at the University of Adelaide. In 1983, he was awarded his Ph.D. in Biological Chemistry from the Australian National University and subsequently undertook post-doctoral studies in Biochemistry at the Universities of Oxford and Adelaide. In 1988, John took up a position as Lecturer in Chemistry at the University of Wollongong where he subsequently became an Associate Professor. In early 2004, he returned to the University of Adelaide as Professor of Chemistry and Head of the School of Chemistry & Physics. In 2008, he became the Deputy Executive Dean of the Faculty of Sciences and, for all of 2009, he was also Head of the School of Molecular and Biomedical Science.
John’s research interests are in peptide and protein structure, function and interactions. Of late, he has been concentrating on molecular chaperone proteins and their mechanism of stabilizing other proteins, particularly those involved in diseases of protein aggregation, e.g. Alzheimer’s and Parkinson’s diseases and cataract. He utilises a diversity of spectroscopic, biophysical and protein chemical techniques for his research, with NMR spectroscopy being at the forefront. He has co-authored over 140 research publications and has received a variety of fellowships.
Presentations this author is a contributor to:
SANS study of the interaction of SANS study of the interaction of αB-crystallin with prefibrillar α-synuclein (#403)
9:00 PM
Aga Rekas
Session 12: Poster Session D - Including Happy Hour & Trade Display
Localisation of the molecular chaperone site of 14-3-3ζ, an intracellular protein associated with toxic neurological protein aggregates (#173)
4:00 PM
Katy L Goodwin
Session 5: Poster Session A
The mechanism and toxicity of amyloid fibril peptides (SEVI) to different cell lines and their enhancement of HIV infection (#172)
4:00 PM
Abigail K Elias
Session 5: Poster Session A